The Path to Drawdown: Contraceptives
Veru, Inc. (stock ticker: VERU) is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancer. They also offer FC2 female condoms that are FDA-approved and cleared by the World Health Organization for purchase by the United Nations. Veru is headquartered in Miami, Florida.
VERU's Role in Drawdown
Veru's Sexual Health Division makes FC2, a female condom for the dual protection against unintended pregnancy and sexually transmitted infections. FC2 is sold commercially in the US and in the public health sector in the US and internationally.
VERU: What We Like
We'll update this section once Veru makes sustainability information available.